首页 › 基金 › Murchinson Ltd. › SLS

Murchinson Ltd. 对 SLS 的持仓历史

SELLAS LIFE SCIENCES GROUP I · 医疗保健

Murchinson Ltd. 在 Q3 2026 的 13F 申报中披露持有 SLS(SELLAS LIFE SCIENCES GROUP I)200,000 股,市值约 US$2.5M,约占其申报组合的 0.47%,在其申报持仓中市值排名第 33 位。 Murchinson Ltd. 于 Q3 2026 首次申报该持仓。

最新持仓 (Q3 2026)200.00K 股
申报持仓市值$2.46M
组合权重0.47%
首次申报Q3 2026
最近变动新进
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Murchinson Ltd. 对 SLS 的持仓演变

Murchinson Ltd. 于 Q3 2026 首次披露 SLS 持仓:200,000 股(约 US$2.5M)。

逐季持仓明细

季度股数金额变化
Q3 2026 200.00K $2.46M 新进

关于 SLS 与 13F 数据

SLS(SELLAS LIFE SCIENCES GROUP I)属于医疗保健行业。我们追踪的基金中还有 108 只申报持有 SLS,申报仓位最大的包括:Anson Funds Management LP (US$38.2M), Sio Capital Management, LLC (US$18.2M), DAGCO, INC. (US$16.5M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 SLS 的基金

查看 SLS 的全部基金持有人 →

常见问题

How long has Murchinson Ltd. held SLS?

Murchinson Ltd. has disclosed SLS holdings in 1 of the last 1 reported quarters, going back to Q3 2026.

What is Murchinson Ltd.'s current position in SLS?

As of Q3 2026, Murchinson Ltd. holds 200.00K shares of SLS (SELLAS LIFE SCIENCES GROUP I), valued at $2.46M, representing 0.47% of its reported portfolio and ranking #33.

Has Murchinson Ltd. been buying or selling SLS?

In the latest 13F filing (Q3 2026), Murchinson Ltd. newly opened its position in SLS.

Which other funds hold SLS?

Other major institutional holders of SLS include Anson Funds Management LP, Sio Capital Management, LLC, DAGCO, INC., among 108 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.